How two academic chemists turned San Diego startup Iambic into an AI force

Announcements

This is some text inside of a div block.

June 18, 2024

Media Contacts

Related announcements

View All

Iambic Therapeutics Closes $50 million Series B Extension to Broaden its Pipeline of AI-Discovered Clinical Oncology Programs

Iambic Therapeutics Closes $50 million Series B Extension to Broaden its Pipeline of AI-Discovered Clinical Oncology Programs

Iambic and NVIDIA: Using AI to chart a faster course for drug discovery

Iambic and NVIDIA: Using AI to chart a faster course for drug discovery

Iambic Therapeutics Announces Poster Presentation for IAM1363, a Clinical Stage Type II HER2 Inhibitor, at the 2024 ASCO Annual Meeting

Iambic Therapeutics Announces Poster Presentation for IAM1363, a Clinical Stage Type II HER2 Inhibitor, at the 2024 ASCO Annual Meeting